INITIAL PSA >=1.5 NG/ML IN MEN = < 50 YEARS OLD PREDICTS A SUBSEQUENT HIGHER RISK OF PROSTATE CANCER

被引：0
|
作者：
Uhlman, Matthew
Tang, Ping
Sun, Leon
Robertson, Cary
Polascik, Thomas
Albala, David
Donatucci, Craig
Moul, Judd
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.1572
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1724
引用
收藏
页码：E666 / E666
页数：1
相关论文
共 50 条
  • [41] Sentinel lymph node resection in prostate cancer patients with PSA higher than 20 NG/ML
    Gronau, E
    Weckermann, D
    Harzmann, R
    JOURNAL OF UROLOGY, 2005, 173 (04): : 437 - 437
  • [42] The role for bone scans in men with high grade prostate cancer and PSA &lt; 20 ng/ml
    Maislos, SD
    Grob, BM
    Terranova, S
    Macchia, R
    JOURNAL OF UROLOGY, 2002, 167 (04): : 224 - 225
  • [43] Detection of prostate cancer in men with prostate-specific antigen (PSA) levels of 2.0 to 4.0ng/ml is equivalent to that in men with 4.1 to 10.0ng/ml in a Japanese population
    Kobayashi, T
    Nishizawa, K
    Mitsumori, K
    Ogura, K
    Ide, Y
    JOURNAL OF UROLOGY, 2004, 171 (04): : 478 - 479
  • [44] PATHOLOGICAL AND ONCOLOGICAL OUTCOMES IN PATIENTS WITH PSA≥10 NG/ML LOW RISK PROSTATE CANCER
    Negrean, Cristina
    Mansour, Mila
    Couture, Felix
    Zorn, Kevin C.
    Zanaty, Marc
    Karakiewicz, Pierre
    Tholomier, Come
    Bhojani, Naeem
    Mounsif, Azizi
    JOURNAL OF UROLOGY, 2018, 199 (04): : E46 - E47
  • [45] Delays in cancer detection using 2 and 4 year screening intervals for prostate cancer screening in men with initial PSA &lt; 2 ng/ml
    Grubb, RL
    Roehl, KA
    Antenor, JAV
    Catalona, WJ
    JOURNAL OF UROLOGY, 2002, 167 (04): : 100 - 100
  • [46] The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng/mL
    Zheng, Xiang-Yi
    Xie, Li-Ping
    Wang, Yu-Yong
    Ding, Wei
    Yang, Kai
    Shen, Hua-Feng
    Qin, Jie
    Bai, Yu
    Chen, Zhao-Dian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (11) : 1207 - 1210
  • [47] Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4 ng/mL
    Sii, Samuel
    Papa, Nathan
    Yiu, Ting Wai
    Tempo, Jake
    Qu, Liang
    Perera, Marlon
    Thompson, Ian
    Ischia, Joseph
    Fleshner, Neil
    Smith, Elliot
    Ranasinghe, Weranja
    Bolton, Damien
    Woon, Dixon T. S.
    BJU INTERNATIONAL, 2025, 135 (04) : 550 - 556
  • [48] Complexed PSA for early detection of prostate cancer in men with serum PSA values of 2-4 ng/mL.
    Cheli, CD
    Horninger, W
    Babaian, R
    Fritsche, H
    Taneja, S
    Lepor, H
    Sokoll, L
    Chan, D
    Childs, S
    CLINICAL CHEMISTRY, 2002, 48 (06) : A15 - A15
  • [49] Prostate-specific antigen velocity in healthy Korean men with initial PSA levels of 4.0 ng/mL or less
    Ham, Won Sik
    Kang, Dae Ryong
    Kim, Young Sig
    Seong, Do Hwan
    Kim, Se Joong
    Cheon, Sang Hyeon
    Cho, In Rae
    Cho, An Seon
    Kim, Chun Il
    Choi, Young Deuk
    UROLOGY, 2008, 72 (01) : 99 - 103
  • [50] Ratio free/total PSA (%f-PSA) in men with total PSA 0.5–3 ng/ml: Improvement for prostate cancer detection?
    Hammerer P.
    Graefen M.
    Henke R.P.
    Haese A.
    Hul E.
    Huland H.
    Prostate Cancer and Prostatic Diseases, 2000, 3 (Suppl 1) : S19 - S19
12345